Anticoagulant use before COVID-19 diagnosis prevent COVID-19 associated acute venous thromboembolism or not: A systematic review and meta-analysis

doi:10.5662/wjm.v14.i3.92983

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 3

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (1688)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-4) series, Tables (1-2) series.

Item

Count

PDF

HTML

1067

Figures (1-4)

174

Tables (1-2)

183

Sum=1486

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

105

Sum=141

Sep 20, 2024 (publication date) through Dec 27, 2024

Times Cited of This Article

Times Cited (1)

Journal Information of This Article

Publication Name

World Journal of Methodology

ISSN

2222-0682

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Meta-Analysis

World J Methodol. Sep 20, 2024; 14(3): 92983
Published online Sep 20, 2024. doi: 10.5662/wjm.v14.i3.92983

Anticoagulant use before COVID-19 diagnosis prevent COVID-19 associated acute venous thromboembolism or not: A systematic review and meta-analysis

Kinza Iqbal, Akshat Banga, Taha Bin Arif, Sawai Singh Rathore, Abhishek Bhurwal, Syeda Kisa Batool Naqvi, Muhammad Mehdi, Pankaj Kumar, Mitali Madhu Salklan, Ayman Iqbal, Jawad Ahmed, Nikhil Sharma, Amos Lal, Rahul Kashyap, Vikas Bansal, Juan Pablo Domecq

Kinza Iqbal, Taha Bin Arif, Syeda Kisa Batool Naqvi, Muhammad Mehdi, Pankaj Kumar, Ayman Iqbal, Jawad Ahmed, Department of Internal Medicine, Dow Medical College, Karachi 74200, Pakistan

Akshat Banga, Department of Internal Medicine, Sawai Man Singh Medical College, Jaipur 302004, India

Sawai Singh Rathore, Department of Internal Medicine, Dr. Sampurnanand Medical College, Jodhpur 342003, Rajasthan, India

Abhishek Bhurwal, Department of Gastroenterology and Hepatology, Rutgers Robert Wood Johnson School of Medicine, New Brunswick, NJ 08901, United States

Mitali Madhu Salklan, Department of Internal Medicine, Pandit Bhagwat Dayal Sharma Post Graduate Institute of Medical Sciences, Rohtak 124001, Haryana, India

Nikhil Sharma, Vikas Bansal, Juan Pablo Domecq, Department of Nephrology and Hypertension, Mayo Clinic, Rochester, MN 55905, United States

Amos Lal, Department of Medicine, Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, MN 55905, United States

Rahul Kashyap, Department of Research, Wellspan Health, York, PA 17403, United States

Co-first authors: Kinza Iqbal and Akshat Banga.

Co-corresponding authors: Vikas Bansal and Juan Pablo Domecq.

Author contributions: Iqbal K and Bansal V contributed equally to defining the study outline and manuscript writing; Data review and collection were done by Banga A, Iqbal A, Ahmed J, Iqbal K, Sharma N, Mehdi M, Kumar P, and Rathore SS; Statistical analysis was done by Banga A, Iqbal K, and Bansal V; Study design and critical review are done by Banga A, Lal A, Domecq JP, Kashyap R, and Bansal V; Iqbal K and Bansal V are the co-corresponding authors of the paper, taking responsibility for the integrity of the work from inception to the published article; all authors contributed to the article and approved the submitted version. Bansal V and Domecq JP contributed equally to this work and are considered co- corresponding authors.

Conflict-of-interest statement: Dr. Bansal has nothing to disclose.

PRISMA 2009 Checklist statement: The authors have read the PRISMA 2009 Checklist, and the manuscript was prepared and revised according to the PRISMA 2009 Checklist.

Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/

Corresponding author: Vikas Bansal, MBBS, Associate Research Scientist, Department of Nephrology and Hypertension, Mayo Clinic, 200 1st St SW, Rochester, MN 55905, Rochester, MN 55905, United States. bansal.vikas@mayo.edu

Received: February 15, 2024
Revised: April 24, 2024
Accepted: May 11, 2024
Published online: September 20, 2024
Processing time: 131 Days and 10.3 Hours

Core Tip

Core Tip: Coronavirus disease 2019 (COVID-19) patients are at an increased risk of developing thromboembolic events and hypercoagulable disorders, which are poor prognostic indicators of COVID-19 disease. The results of different observational studies on the effects of chronic anticoagulation on the mortality and severity of COVID-19 disease in infected patients are inconsistent. This systematic review and meta-analysis provide a comprehensive assessment of the risk of thromboembolic events, mortality, and severity of COVID-19 disease in patients on prehospital anticoagulation treatment.